Medical Journals

Presynaptic Actions of Endocannabinoids Mediate Alpha-msh-induced Inhibition of Oxytocin Cells.

Authors:
  • Sabatier Nancy
  • Leng Gareth

From: Centre for Integrative Physiology, University of Edinburgh, Hugh Robson Bldg, George Square, Edinburgh EH8 9XD, United Kingdom. n.sabatier@ed.ac.uk

American journal of physiology. Regulatory, integrative and comparative physiology

  • Publish Date: Mar 2006
  • ISSN: 0363-6119
  • Volume: 290
  • Issue: 3
  • Pages: R577-84
  • Medium: Print
  • Language: English
  • Citation (JAMA): Sabatier Nancy, Leng Gareth, et al. Presynaptic Actions of Endocannabinoids Mediate Alpha-msh-induced Inhibition of Oxytocin Cells.. Am. J. Physiol. Regul. Integr. Comp. Physiol. Mar 2006;290:R577-84

Abstract

We recently showed that central injections of alpha-melanocyte-stimulating hormone (alpha-MSH) inhibits oxytocin cells and reduces peripheral release of oxytocin, but induces oxytocin release from dendrites. Dendritic oxytocin release can be triggered by agents that mobilize intracellular calcium. Oxytocin, like alpha-MSH, mobilizes intracellular calcium stores in oxytocin cells and triggers presynaptic inhibition of afferent inputs that is mediated by cannabinoids. We hypothesized that this mechanism might underlie the inhibitory effects of alpha-MSH. To test this, we recorded extracellularly from identified oxytocin and vasopressin cells in the anesthetized rat supraoptic nucleus (SON). Retrodialysis of a CB1 cannabinoid receptor antagonist to the SON blocked the inhibitory effects of intracerebroventricular injections of alpha-MSH on the spontaneous activity of oxytocin cells. We then monitored synaptically mediated responses of SON cells to stimulation of the organum vasculosum of the lamina terminalis (OVLT); this evoked a mixed response comprising an inhibitory component mediated by GABA and an excitatory component mediated by glutamate, as identified by the effects of bicuculline and 6-cyano-7-nitroquinoxaline-2,3-dione applied to the SON by retrodialysis. Application of CB1 receptor agonists to the SON attenuated the excitatory effects of OVLT stimulation in both oxytocin and vasopressin cells, whereas alpha-MSH attenuated the responses of oxytocin cells only. Thus alpha-MSH can act as a “switch”; it triggers oxytocin release centrally, but at the same time through initiating endocannabinoid production in oxytocin cells inhibits their electrical activity and hence, peripheral secretion.

Mesh Headings (Keywords): Animals, Endocannabinoids, Female, Neural Inhibition, Neurons, Oxytocin, Rats, Rats, Sprague-Dawley, Supraoptic Nucleus, Synapses, Synaptic Transmission, alpha-MSH


Check for Full Text / PubMed Unique Identifier (PMID): 16269571


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.